ABSTRACT Objective: Gastric adenocarcinoma remains an aggressive disease with a poor prognosis, as evidenced by a 5-year survival rate of approximately 31%. The histological classifications already proposed do not accurately reflect the high biological heterogeneity of this neoplasm, particularly in diverse populations, and new classification systems using genetic markers have recently been proposed. Following these newly proposed models, we aimed to assess the cluster distribution in a Brazilian cohort. Furthermore, we evaluated whether the inclusion of other clinical and histological parameters could enhance the predictive value. Methods: We used a previously described four-immunohistochemistry/EBER-ISH marker to classify a cohort of 30 Brazilian patients with gastric adenocarcinoma into five different clusters and compared the distribution with other genetically diverse populations. Furthermore, we used artificial intelligence methods to evaluate whether other clinical and pathological parameters could improve the results of the methodology. Results: Disclosing the genetic variability between populations, we observed a more balanced distribution of the aberrant/normal p53 ratio (0.6) between patients negative for the other markers tested, unlike previous studies with Asian and North American populations. In addition, decision tree analysis reinforced the efficiency of these new classifications, as the stratification accuracy was not altered with or without additional data. Conclusion: Our study underscores the importance of local research in characterizing diverse populations and highlights the complementary role of molecular biomarkers in personalized medicine for gastric adenocarcinoma, enhancing diagnostic accuracy and potentially improving survival rates. Objective prognosis 5year year 5 31 31% neoplasm models Furthermore value Methods fourimmunohistochemistry/EBERISH fourimmunohistochemistryEBERISH four immunohistochemistry/EBER ISH immunohistochemistry EBER 3 methodology Results aberrantnormal aberrant normal p p5 0.6 06 0 6 (0.6 tested addition data Conclusion rates fourimmunohistochemistry EBERISH immunohistochemistryEBER 0. (0. (0 (

Resumen La fascitis necrotizante es una infección rara y de tejidos blandos caracterizada por una infección de rápida propagación del tejido subcutáneo y, en particular, de la fascia. La fascitis necrotizante tiene un origen polimicrobiano y una necrosis extensa que exhibe formación gaseosa en el tejido subcutáneo y la fascia superficial. El manejo de los tejidos infectados requiere un diagnóstico rápido, una intervención quirúrgica inmediata acompañada de un desbridamiento prolongado y una terapia antibiótica sistémica. El objetivo de este trabajo es relatar un caso raro de fascitis necrotizante de la región cervical-fascial, haciendo hincapié en la importancia del diagnóstico y el tratamiento temprano.

Abstract Necrotizing fasciitis is characterized as a subset of aggressive infections of the skin and soft tissues that cause necrosis of the muscular fascia and subcutaneous tissues. It has a polymicrobial origin and presents an extensive necrosis that exhibits gas formation in the subcutaneous tissue and superficial fascia. The management of infected tissues requires rapid diagnosis, immediate surgical intervention accompanied by extensive debridement and systemic antibiotic therapy. The aim of this paper is to relate a case of an odontogenic necrotizing fasciitis of the cervico-facial region emphasizing the importance of early diagnosis and treatment.

Resumo A fasceite necrotizante é caracterizada como um subconjunto das infecções agressivas da pele e tecidos moles que causam necrose da fáscia muscular e dos tecidos subcutâneos. Tem origem polimicrobiana e apresenta extensa necrose que exibe uma formação gasosa no tecido subcutâneo e fáscia superficial. É fundamental um rápido diagnóstico, seguido de intervenção cirúrgica imediata e antibioticoterapia sistêmica para que se consiga sucesso no tratamento. O objetivo desse artigo é relatar um caso de fasceíte necrotizante em região cérvico-facial com origem odontogênica, ressaltando a importância do diagnóstico e tratamento precoce.